Altered Calcium Homeostasis and Membrane Integrity in Myocardial Cell Injury

  • L. Maximilian Buja
  • Karen P. Burton
  • Kenneth R. Chien
  • James T. Willerson
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 232)


Coronary occlusion leads to contractile arrest of ischemic myocardium and progressive metabolic derangements and ultrastructural alterations, which if of sufficient duration and severity, lead to irreversible myocardial injury. Based on a number of experimental observations, we and others have put forward the following general hypothesis regarding the pathogenesis of irreversible myocardial injury1,2. Myocardial ischemia causes oxygen deprivation which leads to depressed energy metabolism resulting in a reduced ATP level, increased lactate, and decreased pH. The metabolic changes are followed by discrete alterations in energy dependent membrane transport systems which lead to altered ionic composition of the cell, including an increase in cytosolic calcium. These membrane alterations may include altered ionic flux across the sarcolemma as well as release of calcium from mitochondria and sarcoplasmic reticulum. The elevated cytosolic calcium concentration has the potential to activate catabolic enzymes, including phospholipases. This may lead to acceleration phosphlipid degradation, increased membrane permeability, and further electrolyte derangements, including calcium accumulation. The excess cellular calcium load may also lead to ATP depletion by activation of calcium-dependent ATPases as well as by mitochondrial calcium accumulation which occurs at the expense of continued energy production. Thereafter, a vicious cycle of membrane injury and ATP depletion may ensue which terminates in irreversible cell injury. Observations pertinent to this hypothesis are reviewed in this chapter.


Coronary Occlusion Total Phospholipid Calcium Overload Membrane Injury Irreversible Injury 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    W.G. Nayler, The role of calcium in the ischemic myocardium, Am. J. Pathol. 102:262 (1981).PubMedGoogle Scholar
  2. 2.
    J.T. Willerson, A. Mukherjee, K. Chien, C. Ezquierdo, and L.M. Buja, Calcium and acute myocardial infraction, in: “Calcium Antagonists and Cardiovascular Disease”, L.H. Opie, ed., Raven Press, New York, p 257 (1984).Google Scholar
  3. 3.
    K.A. Reimer and R.B. Jennings, The “wavefront phenomenon” of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral blood flow, Lab. Invest. 40:633 (1979).PubMedGoogle Scholar
  4. 4.
    L.M. Buja, A.J. Tofe, P.V. Kulkarni, A. Mukherjee, R.W. Parkey, M.D. Francis, F.J. Bonte, and J.T. Willerson, Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues, J. Clin. Invest. 60:724 (1977).PubMedCrossRefGoogle Scholar
  5. 5.
    J.T. Willerson, F. Scales, A. Mukherjee, M.R. Platt, G.H. Templeton, G.C. Fink, and L.M. Buja, Abnormal myocardial fluid retention as an early manifestation of ischemic injury, Am. J. Pathol. 87:159 (1977).PubMedGoogle Scholar
  6. 6.
    L.M. Buja and J.T. Willerson, Abnormalities of volume regulation and membrane integrity in myocardial tissue slices after early ischemic injury in the dog: Effects of mannitol, polyethylene glycol and propranolol, Am. J. Path. 103:79 (1981).PubMedGoogle Scholar
  7. 7.
    K.I. Shine, Ionic events in ischemia and anoxia, Am. J. Pathol. 102:256 (1981).PubMedGoogle Scholar
  8. 8.
    K.P. Burton, H.K. Hagler, G.H. Templeton, J.T. Willerson, and L.M. Buja, Lanthanum probe studies of cellular pathophysiology induced by hypoxia in isolated cardiac muscle, J. Clin. Invest. 60:1289 (1977).PubMedCrossRefGoogle Scholar
  9. 9.
    K.P. Burton, H.K. Hagler, J.T. Willerson, and L.M. Buja, Relationship of abnormal intracellular lanthanum accumulation to progression of ischemic injury in isolated perfused myocardium; effect of chlorpro-mazine, Am. J. Physiol. 241:H714 (1981).PubMedGoogle Scholar
  10. 10.
    L.M. Buja, K.P. Burton, H.K. Hagler, and J.T. Willerson, Alterations of elemental composition of individual myocytes in hypoxic rabbit myocardium: a quantitative x-ray microanalytical study, Circ. 68:872 (1983).CrossRefGoogle Scholar
  11. 11.
    A. Mukherjee, T.M. Wong, G.H. Templeton, L.M. Buja, and J.T. Willerson, Influence of volume dilution, lactate, phosphate and calcium on mitochondrial functions, Am. J. Physiol. 237:H224 (1979).PubMedGoogle Scholar
  12. 12.
    A. Mukherjee, T.M. Wong, L.M. Buja, R.J. Lefkowitz, and J.T. Willerson, Beta adrenergic and muscarinic cholinergic receptors in canine myocardium: Effects of ischemia, J. Clin. Invest. 64:1423 (1979).PubMedCrossRefGoogle Scholar
  13. 13.
    A. Mukherjee, L. Bush, K.E. McCoy, R.J. Duke, H.K. Hagler, L.M. Buja, and J.T. Willerson, Relationship between B-adrenergic receptor numbers and physiologic responses during experimental canine myocardial ischemia, Cir. Res. 50:735 (1982).CrossRefGoogle Scholar
  14. 14.
    K.H. Muntz, H.K. Hagler, H.J. Boulas, J.T. Willerson, and L.M. Buja, Redistribution of catecholamines in the ischemic zone of the dog heart, Am. J. Pathol. 114:64 (1984).PubMedGoogle Scholar
  15. 15.
    P.B. Corr, J.A. Shayman, J.B. Kramer, and R.J. Kipnis, Increased alpha adrenergic receptors in ischemic cat myocardium: a potential mediator of electrophysiological derangements, J. Clin. Invest. 67:1232 (1981).PubMedCrossRefGoogle Scholar
  16. 16.
    L.M. Buja, H.K. Muntz, T. Rosenbaum, Z. Haghani, D.K. Buja, A. Sen, K.R. Chien, and J.T. Willerson, Characterization of a potentially reversible increase in beta adrenergic receptors in isolated, neonatal rat cardiac myocytes with impaired energy metabolism, Cir. Res. 57:640 (1985).CrossRefGoogle Scholar
  17. 17.
    A.S. Maisel, H.J. Motulsky, P.A. Insel, Externalization of B-adrenergic receptors promoted by myocardial ischemia, Science 230:183 (1985).PubMedCrossRefGoogle Scholar
  18. 18.
    A.M. Katz and F.C. Messineo, Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium, Circ. Res. 48:1 (1981).PubMedCrossRefGoogle Scholar
  19. 19.
    R. Franson, D.C. Pang, D.W. Towle, W.B. Weglicki, Phospholipase A activity of highly enriched preparations of cardiac sarcolemma from hamster and dog, J. Mol. Cell. Cardiol. 10:921 (1978).PubMedCrossRefGoogle Scholar
  20. 20.
    K.Y. Hostetler, and L.B. Hall, Phospholipase C activity of rat tissues, Biochem. Biophys. Res. Comm. 96:388 (1980).PubMedCrossRefGoogle Scholar
  21. 21.
    K.R. Chien, J. Abrams, A. Serroni, J.T. Martin, and J.L. Farber, Accelerated phospholipid degradation and associated membrane dysfunction in irreversible, ischemic liver cell injury, J. Biol. Chem. 253:4809 (1978).PubMedGoogle Scholar
  22. 22.
    K.R. Chien, J.P. Reeves, L.M. Buja, F.J. Bonte, R.W. Parkey, and J.T. Willerson, Phospholipid alterations in canine ischemic myocardium. Temporal and topographical correlations with Tc-99m-PPi accumulation and an in vitro sarcolemmal Ca2+ permeability defect, Cir. Res. 48:711 (1981).CrossRefGoogle Scholar
  23. 23.
    K.R. Chien, A. Han, A. Sen, L.M. Buja, and J.T. Willerson, Accumulation of unesterified arachidonic acid in ischemic canine myocardium: relationship to a phosphatidylcholine deacylation-reacylation cycle and depletion of membrane phospholipids, Cir. Res. 54:313 (1984).CrossRefGoogle Scholar
  24. 24.
    K.P. Burton, L.M. Buja, A. Sen, J.T. Willerson, and K.R. Chien, Accumulation of arachidonate in triacylglycerols and unesterified fatty acids during ischemia and reflow in the isolated rat heart: correlation with the loss of contractile function and the development of calcium overload, Am. J. Pathol. 124:238 (1986).PubMedGoogle Scholar
  25. 25.
    L.M. Buja, H.K. Hagler, D. Parsons, K. Chien, R.C. Reynolds, and J.T. Willerson, Alterations of ultrastructure and elemental composition in cultured neonatal rat cardiac myocytes following metabolic inhibition with iodoacetic acid, Lab. Invest. 53:397 (1985).PubMedGoogle Scholar
  26. 26.
    K.R. Chien, A. Sen, R.C. Reynolds, A. Chang, Y. Kim, M.D. Gunn, L.M. Buja, and J.T. Willerson, Release of arachidonate from membrane phospholipids in cultured myocardial cells during ATP depletion: correlation with the progression of cell injury, J. Clin. Invest. 75:1770 (1985).PubMedCrossRefGoogle Scholar
  27. 27.
    M.D. Gunn, A. Sen, A. Chang, J.T. Willerson, L.M. Buja, and K.R. Chien, Mechanisms of accumulation of arachidonic acid in cultured myocardial cells during ATP depletion, Am. J. Physiol. 249:H1188 (1985).Google Scholar
  28. 28.
    L.M. Buja, P.K. Williams, D.K. Buja, K.R. Chien, and J.T. Willerson, Comparative effects of cardiac myocyte injury induced by inhibition of the Na+, K+ pump and intermediary metabolism, Clin. Res. 34:627A (1986).Google Scholar
  29. 29.
    A.C. Morris, P.K. Williams, F.A. Lattanzio, D.J. Bellotto, H.K. Hagler, J.T. Willerson, and L.M. Buja, Altered calcium homeostasis induced by Na+, K+ pump inhibition in cultured ventricular myocytes, Circulation 74 (Suppl II): 11–418 (1986).Google Scholar
  30. 30.
    D.K. Das, R.M. Engleman, J.A. Rousou, R.H. Breyer, H. Otani, and S. Lemeshow, Role of membrane phospholipids in myocardial injury induced by ischemia and reperfusion, Am. J. Physiol. 251:H71 (1986).Google Scholar
  31. 31.
    K. Chien, A. Sen, Y. Kim, K. Burton, L.M. Buja, and J.T. Willerson, Biochemical characterization of a new synthetic myocardial phospho-lipase inhibitor: effects on myocardial cells during ATP depletion, Circulation 70 (Suppl II): II278 (1984).Google Scholar
  32. 32.
    P.B. Corr, R.W. Gross, and B.E. Sobel, Amphiphatic metabolites and membrane dysfunction in ischemic myocardium, Circ. Res. 55:135 (1984).PubMedCrossRefGoogle Scholar
  33. 33.
    K.R. Chien, A. Sen, L.M. Buja, and J.T. Willerson, Fatty acylcarnitine accumulation and membrane injury in ischemic canine myocardium, Am. J. Cardiol. 52:893 (1983).PubMedCrossRefGoogle Scholar
  34. 34.
    K.P. Burton, Superoxide dismutase enhances recovery following myocardial ischemia, Am. J. Physiol. 248:H637 (1985).PubMedGoogle Scholar
  35. 35.
    S.W. Werns, M.J. Shea, and B.R. Lucchesi, Free radicals and myocardial injury: pharmacologic implications, Circulation 74:1 (1986).PubMedCrossRefGoogle Scholar
  36. 36.
    C. Steenbergen, M.L. Hill, and R.B. Jennings, Volume regulation and plasma membrane injury in aerobic, anaerobic, and ischemic myocardium in vitro: effects of osmotic cell swelling on plasma membrane integrity, Circ. Res. 57:864 (1985).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • L. Maximilian Buja
    • 1
  • Karen P. Burton
    • 1
  • Kenneth R. Chien
    • 1
  • James T. Willerson
    • 1
  1. 1.Departments of Pathology, Physiology, and Internal Medicine (Cardiology Division)The University of Texas Health Science Center at DallasDallasUSA

Personalised recommendations